The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Dietary carbohydrates and fats in nonalcoholic fatty liver disease
Open accessAbstract
The global prevalence of nonalcoholic fatty liver disease (NAFLD) has dramatically increased in parallel with the epidemic of obesity. Controversy has emerged around dietary guidelines recommending low-fat-high-carbohydrate diets and the roles of dietary macronutrients in the pathogenesis of metabolic disease. In this Review, the topical questions of whether and how dietary fats and carbohydrates, including free sugars, differentially influence the accumulation of liver fat (specifically, intrahepatic triglyceride (IHTG) content) are addressed. Focusing on evidence from humans, we examine data from stable isotope studies elucidating how macronutrients regulate IHTG synthesis and disposal, alter pools of bioactive lipids and influence insulin sensitivity. In addition, we review cross-sectional studies on dietary habits of patients with NAFLD and randomized controlled trials on the effects of altering dietary macronutrients on IHTG. Perhaps surprisingly, evidence to date shows no differential effects between free sugars, with both glucose and fructose increasing IHTG in the context of excess energy. Moreover, saturated fat raises IHTG more than polyunsaturated or monounsaturated fats, with adverse effects on insulin sensitivity, which are probably mediated in part by increased ceramide synthesis. Taken together, the data support the use of diets that have a reduced content of free sugars, refined carbohydrates and saturated fat in the treatment of NAFLD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypocaloric low-carbohydrate diets and low-fat diets appear to be similarly effective in reducing liver lipid content and related biomarkers. 289,290”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [289]
In the citing paper
“Saturated fat has been shown to have a negative effect on liver steatosis in several short-term clinical trials. 289”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [289]
In the citing paper
“Intake of added sugars, especially fructose, plays a major role in MASLD development. 289”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [289]
Citations
Cites
Items 201–221 of 221
Vitamin D and nonalcoholic fatty liver disease
Zhang, Z., Thorne, J. L., & Moore, J. B. (2019) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000605 · Cited by 45
Self-citationAcetoacetate and 3-hydroxybutyrate kinetics in obese and insulin-dependent diabetic humans
Nosadini, R., Avogaro, A., Trevisan, R., Duner, E., Marescotti, C., Iori, E., Cobelli, C., & TOFFOLO, G. M. (1985) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1985.248.5.r611 · Cited by 44
Rehm, J. T., & Patra, J. (2011) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2011.00395.x · Cited by 43
Umpleby, A. M., Shojaee‐Moradie, F., Fielding, B. A., Li, X., Marino, A., Jawad, N. M. M., Isherwood, C., Jackson, N., Ahmad, A., Stolinski, M., et al. (2017) · Clinical Science · doi:10.1042/cs20171208 · Cited by 41
Maldonado, E. M., Fisher, C., Mazzatti, D. J., Barber, A. L., Tindall, M. J., Plant, N. J., Kierzek, A. M., & Moore, J. B. (2018) · npj Systems Biology and Applications · doi:10.1038/s41540-018-0070-3 · Cited by 37
Self-citationMoore, J. B., & Fielding, B. A. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000289 · Cited by 36
Self-citationBowser, S. M., McMillan, R. P., Boutagy, N. E., Tarpey, M. D., Smithson, A. T., Osterberg, K. L., Neilson, A. P., Davy, B. M., Davy, K. P., & Hulver, M. W. (2019) · Metabolism · doi:10.1016/j.metabol.2019.154041 · Cited by 36
Bozzetto, L., Costabile, G., Luongo, D., Naviglio, D., Cicala, V., Piantadosi, C., Patti, L., Cipriano, P., Annuzzi, G., & Rivellese, A. A. (2016) · Diabetologia · doi:10.1007/s00125-016-4110-5 · Cited by 35
Metabolic effects of a prolonged, very-high-dose dietary fructose challenge in healthy subjects
Smajis, S., Gajdošík, M., Pfleger, L., Traussnigg, S., Kienbacher, C., Halilbasic, E., Ranzenberger-Haider, T., Stangl, A., Beiglböck, H., Wolf, P. S., et al. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz271 · Cited by 35
Weiss, M., Keller, U. B., & Stauffacher, W. (1984) · Diabetes · doi:10.2337/diab.33.8.738 · Cited by 34
Davy, B. M., & Estabrooks, P. A. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.05.009 · Cited by 26
Nouws, J., Fitch, M. D., Mata, M., Santoro, N., Galuppo, B., Kursawe, R., Narayan, D., Vash‐Margita, A., Pierpont, B. M., Shulman, G. I., et al. (2019) · Diabetes · doi:10.2337/db18-1162 · Cited by 24
Oxidation of dietary linoleate occurs to a greater extent than dietary palmitate in vivo in humans
Parry, S. A., Rosqvist, F., Cornfield, T., Barrett, A., & Hodson, L. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.07.013 · Cited by 24
Self-citationChallenging metabolic tissues with fructose: tissue‐specific and sex‐specific responses
Pinnick, K. E., & Hodson, L. (2019) · The Journal of Physiology · doi:10.1113/jp277115 · Cited by 23
Self-citationGetting energy balance right in an obesogenic world
Moore, J. B., & Boesch, C. (2019) · Proceedings of The Nutrition Society · doi:10.1017/s0029665118002720 · Cited by 16
Self-citationCeramide stearic to palmitic acid ratio predicts incident diabetes
Hilvo, M., Salonurmi, T., Havulinna, A. S., Kauhanen, D., Pedersen, E. R., Tell, G. S., Meyer, K., Teeriniemi, A.-M., Laatikainen, T. K., Jousilahti, P., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4590-6 · Cited by 9
Sugar, not fat, is the culprit
Lim, D. C. G. (2013) · BMJ · doi:10.1136/bmj.f6846 · Cited by 7
We need more data before rejecting the saturated fat hypothesis
Clifton, P. M. (2013) · BMJ · doi:10.1136/bmj.f6847 · Cited by 6
Green, C., Pramfalk, C., Charlton, C. A., Gunn, P. J., Cornfield, T., Pavalides, M., Karpe, F., & Hodson, L. (2019) · Endocrine Abstracts · doi:10.1530/endoabs.65.oc1.2 · Cited by 6
Self-citationMajor report backs overhaul of US dietary guideline process
Wise, J. (2017) · BMJ · doi:10.1136/bmj.j4340 · Cited by 4
[Early determination and proper follow-up of pregnancy].
Boldu, D. (1988) · PubMed · Cited by 1
Flagged first, then by citations
Cited by
Sorted by citations
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210
Self-citationLifestyle interventions in nonalcoholic fatty liver disease
Younossi, Z. M., Zelber-Sagi, S., Henry, L., & Gerber, L. H. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00800-4 · Cited by 281
Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
Huttasch, M., Roden, M., & Kahl, S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155937 · Cited by 169
Chooi, Y. C., Zhang, Q. A., Magkos, F., Ng, M., Michael, N., Wu, X., Volchanskaya, V. S. B., Lai, X., Wanjaya, E. R., Elejalde, U., et al. (2024) · The American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.11.013 · Cited by 69
Metadata
- Authors
- Yki-Järvinen, H., Luukkonen, P. K., Hodson, L., & Moore, J. B.
- Affiliations
- University of Helsinki (FI)
- University of Oxford (GB)
- University of Leeds (GB)
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2021-07-13
- Volume
- 18
- Issue
- 11
- Pages
- 770-786
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W3178703016
- Cited by
- 294
- References
- 221
- Citations by year
- 2026: 51 · 2025: 81 · 2024: 67 · 2023: 41 · 2022: 46 · 2021: 8
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- green
- ora.ox.ac.uk
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Oxford University Research Archive (ORA) (University of Oxford) (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion)
- Funders
- British Heart Foundation (FS/15/56/31645)
- Novo Nordisk
- Novo Nordisk Fonden (NNF18OC0054504, NNF19OC0057503)
- Biotechnology and Biological Sciences Research Council (BBS/E/F/000PR10347, BB/N005600/1, BBS/E/F/00044434)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- non-alcoholic fatty liver disease, dietary carbohydrates, dietary fat, free sugars, fructose, glucose, saturated fat, polyunsaturated fat, monounsaturated fatty acids, intrahepatic triglyceride, hepatic lipid accumulation, insulin sensitivity, ceramide synthesis, bioactive lipids, macronutrient metabolism, obesity, low-fat high-carbohydrate diet
- MeSH terms
- Dietary Sugars, Ceramides, Dietary Carbohydrates, Dietary Fats, Dietary Fats, Unsaturated, Fructose, Glucose, Humans, Insulin Resistance, Liver, Triglycerides, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
